Why results may differ after switching Wegovy clinics
If you notice a change in results after moving between clinics while using Wegovy (semaglutide), this is very unlikely to be related to the medication itself. All Wegovy supplied in the UK must meet the same regulatory requirements and contains the same active ingredient at the prescribed strength. Differences in results are more commonly explained by factors such as eating habits, calorie intake, physical activity, breaks in treatment, dose timing, or how your body responds over time. It is also normal for weight loss to slow as your body adapts, regardless of which clinic issues the prescription.
At medino, Wegovy is obtained exclusively from fully licensed UK wholesalers. All pens are genuine, regulated medicines supplied through approved pharmaceutical supply chains and handled in accordance with UK medicines regulations. When Wegovy is prescribed and supplied correctly, there is no variation in formulation, strength, or quality between providers. If outcomes change after switching clinics, a clinical review can help assess dosing, adherence, lifestyle factors, and treatment expectations.
- Wegovy pens are the same across UK clinics when sourced from licensed wholesalers
- Changes in results are usually linked to lifestyle or body adaptation, not product quality
- Interruptions to treatment, dose adjustments, or timing differences can affect progress
- Weight loss commonly slows over time, regardless of provider
- All medino supplies are genuine, UK-regulated medicines from approved suppliers
This text has been fact-checked for accuracy by Sorin Romaniuc, Pharmacist at medino.